ArticleBone marrow transplantation2014

Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

P Chevallier et al.PubMed ↗Publisher ↗

No numbers read from the abstract.